The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A Fatty Acid Synthase Blockade Induces Tumor Cell-cycle Arrest by Down-regulating Skp2
Open accessAbstract
In eukaryotes, fatty acid synthase (FAS) is the enzyme responsible for synthesis of palmitate, the precursor of long-chain nonessential fatty acids. FAS is up-regulated in a wide range of cancers and has been suggested as a relevant drug target. Here, two independent approaches are taken toward knocking down FAS and then probing its connection to tumor cell proliferation. In one approach, Orlistat, a drug approved for treating obesity, is used as a potent inhibitor of the thioesterase function of FAS. In a separate strategy, the expression of FAS is suppressed by targeted knock-down with small interfering RNA. In both circumstances, the ablation of FAS activity causes a dramatic down-regulation of Skp2, a component of the E3 ubiquitin ligase that controls the turnover of p27Kip1. These effects ultimately tie into the retinoblastoma protein pathway and lead to a cell-cycle arrest at the G1/S boundary. Altogether, the findings of the study reveal unappreciated links between fatty acid synthase and ubiquitin-dependent proteolysis of cell-cycle regulatory proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FASN can promote cancer progression and contribute to therapy resistance by sustaining mitogenic signaling, facilitating the G1/S transition, and supplying lipid resources necessary for biomass accumulation and evasion of cell cycle checkpoints [30,48].”
From Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer (2026) · cites this paper as [48]
Citations
Cites
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,544
Activity-based protein profiling: The serine hydrolases
Liu, Y., Patricelli, M. P., & Cravatt, B. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14694 · Cited by 1,143
Weir, H. K. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg040 · Cited by 864
Fatty acid synthesis: a potential selective target for antineoplastic therapy
Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D., & Pasternack, G. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6379 · Cited by 705
Insights into SCF ubiquitin ligases from the structure of the Skp1–Skp2 complex
Schulman, B. A., Carrano, A. C., Jeffrey, P. D., Bowen, Z., Kinnucan, E., Finnin, M. S., Elledge, S. J., Harper, J. W., Pagano, M., & Pavletich, N. P. (2000) · Nature · doi:10.1038/35042620 · Cited by 610
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Kridel, S. J., Axelrod, F. T., Rozenkrantz, N., & Smith, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3645 · Cited by 610
Self-citationSynthesis and antitumor activity of an inhibitor of fatty acid synthase
Kuhajda, F. P., Pizer, E. S., Li, J. N., Mani, N. S., Frehywot, G. L., & Townsend, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3450 · Cited by 568
Profiling Serine Hydrolase Activities in Complex Proteomes
Kidd, D., Liu, Y., & Cravatt, B. F. (2001) · Biochemistry · doi:10.1021/bi002579j · Cited by 369
Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma.
Milgraum, L. Z., Witters, L. A., Pasternack, G. R., & Kuhajda, F. P. (1997) · PubMed · Cited by 333
Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
Pizer, E. S., Jackisch, C., Wood, F. D., Pasternack, G. R., Davidson, N. E., & Kuhajda, F. P. (1996) · PubMed · Cited by 291
Research works printed but not linked: 7
- Milgraum, 1997, Clin. Cancer Res., 3, 2115
- Furuya, 1997, Anticancer Res., 17, 4589
- Pizer, 1996, Cancer Res., 56, 2745
- Pizer, 1998, Cancer Res., 58, 4611
- Li, 2001, Cancer Res., 61, 1493
- Pizer, 1996, Cancer Res., 56, 745
- Yang, 2002, Clin. Cancer Res., 8, 3419
Cited by
Sorted by citations
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Targeting cellular metabolism to improve cancer therapeutics
Zhao, Y., Butler, E. B., & Tan, M. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.60 · Cited by 1,010
Fatty Acid Synthase As a Potential Therapeutic Target in Cancer
Flavin, R., Peluso, S., Nguyen, P. L., & Loda, M. F. (2010) · Future Oncology · doi:10.2217/fon.10.11 · Cited by 545
Disruption of Hepatic Adipogenesis Is Associated With Impaired Liver Regeneration in Mice
Shteyer, E., Liao, Y., Muglia, L. J., Hruz, P. W., & Rudnick, D. A. (2004) · Hepatology · doi:10.1002/hep.20462 · Cited by 234
Yang, P., Liu, K., Ngai, M. H., Lear, M. J., Wenk, M. R., & Yao, S. Q. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907716f · Cited by 235
Świerczyński, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2279 · Cited by 203
Hess, D., Chisholm, J. W., & Igal, R. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011394 · Cited by 195
Cellitti, S. E., Jones, D. H., Lagpacan, L., Hao, X., Zhang, Q., Hu, H., Brittain, S. M., Brinker, A., Caldwell, J. S., Bursulaya, B. D., et al. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801602q · Cited by 191
Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
Ali, A., Levantini, E., Teo, J. T., Goggi, J., Clohessy, J. G., Wu, C., Chen, L., Yang, H. H., Krishnan, I., Kocher, O. N., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708313 · Cited by 187
Inhibition of Fatty Acid Synthase Induces Endoplasmic Reticulum Stress in Tumor Cells
Little, J. L., Wheeler, F. B., Fels, D. R., Koumenis, C., & Kridel, S. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1794 · Cited by 181
Menéndez, J. A., Vellón, L., & Lupu, R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi239 · Cited by 184
Carvalho, M. A., Zecchin, K. G., Seguin, F., Bastos, D. C., Agostini, M., Rangel, A. L. C. A., Veiga, S. S., Raposo, H. F., Oliveira, H. C. F., Loda, M. F., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23835 · Cited by 171
Mechanism of Apoptosis Induced by the Inhibition of Fatty Acid Synthase in Breast Cancer Cells
Bandyopadhyay, S., Zhan, R., Wang, Y., Pai, S. K., Hirota, S., Hosobe, S., Takano, Y., Saito, K., Furuta, E., Iiizumi, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3197 · Cited by 165
Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism
Igal, R. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.009 · Cited by 166
Seguin, F., Carvalho, M. A., Bastos, D. C., Agostini, M., Zecchin, K. G., Flores, M. P. A., Chudzinski-Tavassi, A. M., Coletta, R. D., & Graner, E. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.355 · Cited by 154
Sadowski, M. C., Pouwer, R. H., Gunter, J. H., Lubik, A. A., Quinn, R. J., & Nelson, C. C. (2014) · Oncotarget · doi:10.18632/oncotarget.2433 · Cited by 147
Liu, H., Liu, J., Wu, X., & Zhang, J. (2010) · PubMed Central · Cited by 141
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
Schcolnik‐Cabrera, A., Chávez-Blanco, A. D., Domínguez-Gómez, G., Taja‐Chayeb, L., Morales‐Bárcenas, R., Trejo‐Becerril, C., Pérez‐Cárdenas, E., González‐Fierro, A., & Dueñas‐González, A. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1471132 · Cited by 143
Inhibition of fatty acid synthase prevents preadipocyte differentiation
Schmid, B., Rippmann, J. F., Tadayyon, M., & Hamilton, B. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.067 · Cited by 138
Agostini, M., Almeida, L. Y., Bastos, D. C., Ortega, R. M., Moreira, F. S., Seguin, F., Zecchin, K. G., Raposo, H. F., Oliveira, H. C. F., Amoêdo, N. D., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1136 · Cited by 131
Papaevangelou, E., de Almeida, G. S., Box, C., deSouza, N. M., & Chung, Y. (2018) · International Journal of Cancer · doi:10.1002/ijc.31392 · Cited by 124
Birsoy, K., Berry, R., Wang, T., Ceyhan, O., Tavazoie, S., Friedman, J. M., & Rodeheffer, M. S. (2011) · Development · doi:10.1242/dev.067710 · Cited by 109
Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers.
Yang, Y., Liu, H., Li, Z., Zhao, Z., Yip-Schneider, M., Fan, Q., Schmidt, C. M., Chiorean, E. G., Xie, J., Liang Cheng, C., et al. (2011) · PubMed Central · Cited by 109
Knowles, L. M., Chen, Y., Osterman, A. L., & Smith, J. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803384200 · Cited by 100
Self-citationFatty acid synthase inhibitors: new directions for oncology
Kridel, S. J., Lowther, W. T., & Pemble, C. W., IV (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.11.1817 · Cited by 90
McFadden, J. M., Medghalchi, S. M., Thupari, J. N., Pinn, M. L., Vadlamudi, A., Miller, K. I., Kuhajda, F. P., & Townsend, C. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049389h · Cited by 89
Nasheri, N., Joyce, M., Rouleau, Y., Yang, P., Yao, S. Q., Tyrrell, D. L., & Pezacki, J. P. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.03.014 · Cited by 88
Lipases or Esterases: Does It Really Matter? Toward a New Bio-Physico-Chemical Classification
Ali, Y. B., Verger, R., & Abousalham, A. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-600-5_2 · Cited by 88
Uncovering the metabolomic fingerprint of breast cancer
Oakman, C. A., Tenori, L., Biganzoli, L., Santarpia, L., Cappadona, S., Luchinat, C., & Leo, A. D. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.001 · Cited by 85
Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions
Saleh, A. A., El‐Fayoumi, H. M., Youns, M., & Barakat, W. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1579-0 · Cited by 83
Lee, J., Lee, M. S., Oh, W. K., & Sul, J. Y. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1427 · Cited by 83
Polyunsaturated fatty acid metabolism in prostate cancer
Berquin, I. M., Edwards, I. J., Kridel, S. J., & Chen, Y. Q. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9299-7 · Cited by 81
Prognostic impact of Skp2 and p27 in human breast cancer
Traub, F., Mengel, M., Lück, H. J., Kreipe, H. H., & von Wasielewski, R. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9202-3 · Cited by 80
Purohit, V. C., Richardson, R. D., Smith, J. W., & Romo, D. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo060392d · Cited by 80
Self-citationPelletier, L., Rebouissou, S., Paris, A., Rathahao, E., Perdu-Durand, E., Bioulac‐Sage, P., Imbeaud, S., & Zucman‐Rossi, J. (2009) · Hepatology · doi:10.1002/hep.23362 · Cited by 84
Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis
Zecchin, K. G., Rossato, F. A., Raposo, H. F., de Melo, D. R., Alberici, L. C., Oliveira, H. C. F., Castilho, R. F., Coletta, R. D., Vercesi, A. E., & Graner, E. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.157 · Cited by 76
Pinweha, P., Rattanapornsompong, K., Charoensawan, V., & Jitrapakdee, S. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.05.005 · Cited by 75
Ma, G., Zancanella, M. A., Oyola, Y., Richardson, R. D., Smith, J. W., & Romo, D. (2006) · Organic Letters · doi:10.1021/ol061651o · Cited by 75
Self-citationKull, T., Cabrera, J., & Peters, R. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201000840 · Cited by 74
Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production
Liu, H., Wu, X., Dong, Z., Luo, Z., Zhao, Z., Xu, Y., & Zhang, J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m033811 · Cited by 75
Kremer, L., de Chastellier, C., Dobson, G., Gibson, K. J. C., Bifani, P. J., Balor, S., Gorvel, J., Locht, C., Minnikin, D. E., & Besra, G. S. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04717.x · Cited by 71
Dowling, S. C., Cox, J., & Cenedella, R. J. (2009) · Lipids · doi:10.1007/s11745-009-3298-2 · Cited by 67
Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication
Wilsky, S., Sobotta, K., Wiesener, N., Pilas, J., Althof, N., Münder, T., Wutzler, P., & Henke, A. (2011) · Archives of Virology · doi:10.1007/s00705-011-1164-z · Cited by 63
Gerosuppressant Metformin: less is more
Menéndez, J. A., Cufí, S., Oliveras‐Ferraros, C., Vellón, L., Joven, J., & Vázquez‐Martín, A. (2011) · Aging · doi:10.18632/aging.100316 · Cited by 57
Dengler, M. A., Weilbacher, A., Gutekunst, M., Staiger, A. M., Vöhringer, M. C., Horn, H., Ott, G., Aulitzky, W. E., & van der Kuip, H. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.552 · Cited by 57
Click-based synthesis and proteomic profiling of lipstatin analogues
Ngai, M. H., Yang, P., Liu, K., Shen, Y., Wenk, M. R., Yao, S. Q., & Lear, M. J. (2010) · Chemical Communications · doi:10.1039/c0cc01276a · Cited by 55
Meier, P., Broghammer, F., Latendorf, K., Rauhut, G., & Peters, R. (2012) · Molecules · doi:10.3390/molecules17067121 · Cited by 55
Tiss, A., Lengsfeld, H., Carrière, F., & Verger, R. (2008) · Journal of Molecular Catalysis B Enzymatic · doi:10.1016/j.molcatb.2008.11.003 · Cited by 55
3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors
Rivkin, A., Kim, Y. R., Goulet, M. T., Bays, N. W., Hill, A. D., Kariv, I., Krauss, S., Ginanni, N., Strack, P. R., Kohl, N. E., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.06.014 · Cited by 55
Gastrointestinal stromal tumours overexpress fatty acid synthase
Rossi, S., Ou, W., Tang, D., Bhattacharya, N., Tos, A. P. D., Fletcher, J. A., & Loda, M. F. (2006) · The Journal of Pathology · doi:10.1002/path.1983 · Cited by 54
Lipid Biosynthesis and its Coordination with Cell Cycle Progression
Kwok, A. C. M., & Wong, J. T. Y. (2005) · Plant and Cell Physiology · doi:10.1093/pcp/pci213 · Cited by 53
Wang, C. J., Li, D., Danielson, J. A., Zhang, E. H., Dong, Z., Miller, K. D., Li, L., Zhang, J.-T., & Liu, J.-Y. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.026 · Cited by 51
Wang, Q., Zhang, W., Liu, Q., Zhang, X., Lv, N., Ye, L., & Zhang, X. (2010) · Neoplasia · doi:10.1593/neo.91298 · Cited by 51
Hadrich, F., Cher, S., Gargouri, Y. T., & Adel, S. (2014) · Journal of Oleo Science · doi:10.5650/jos.ess13163 · Cited by 49
Bastos, D. C., Paupert, J., Maillard, C., Seguin, F., Carvalho, M. A., Agostini, M., Coletta, R. D., Noël, A., & Graner, E. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.125 · Cited by 49
Synthesis of Novel β-Lactone Inhibitors of Fatty Acid Synthase
Richardson, R. D., Ma, G., Oyola, Y., Zancanella, M. A., Knowles, L. M., Cieplak, P., Romo, D., & Smith, J. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800321h · Cited by 49
Self-citationTruong, M., Hwang, Y. P., Kim, H. G., Na, M., & Jeong, H. G. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24258 · Cited by 48
Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer
Knowles, L. M., & Smith, J. W. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-168 · Cited by 49
Self-citationvan Duijn, P. W., & Trapman, J. (2006) · The Prostate · doi:10.1002/pros.20398 · Cited by 46
Kant, S., Kumar, A., & Singh, S. M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.010 · Cited by 44
Shahab Uddin, M. S., Hussain, A. R., Ahmed, M., Abubaker, J. A., Al-Sanea, N. A., Abduljabbar, A. S., Ashari, L. H. S., Alhomoud, S. J., Al‐Dayel, F., Bavi, P. P., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.230 · Cited by 43
Kao, Y., Lee, S., Lin, L.-C., Chen, L., Hsing, C., Hsu, H.-P., Huang, H.-Y., Shiue, Y.-L., Chen, T.-J., & Li, C. (2012) · Tumor Biology · doi:10.1007/s13277-012-0605-y · Cited by 43
Link between obesity and cancer: role of triglyceride/free fatty acid cycling.
Gong, Y., Lj, D., & Liang, J. (2014) · PubMed · Cited by 43
Fatty acid synthase inhibition results in a magnetic resonance–detectable drop in phosphocholine
Ross, J. R., Najjar, A. M., Sankaranarayanapillai, M., Tong, W. P., Kaluarachchi, K., & Ronen, S. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0015 · Cited by 43
Rossato, F. A., Zecchin, K. G., Guardia, P. G. L., Ortega, R. M., Alberici, L. C., Costa, R. A. P. E., Catharino, R. R., Graner, E., Castilho, R. F., & Vercesi, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101060 · Cited by 43
Fatty Acid Synthase Activity in Tumor Cells
Little, J. L., & Kridel, S. J. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_7 · Cited by 43
Chen, Y., Richardson, A. D., Osterman, A. L., & Smith, J. W. (2007) · Metabolomics · doi:10.1007/s11306-007-0094-y · Cited by 41
Self-citationStructure–Activity Relationship of Polyphenols That Inhibit Fatty Acid Synthase
Li, B.-H., Ma, X., Wang, Y., & Tian, W. (2005) · The Journal of Biochemistry · doi:10.1093/jb/mvi171 · Cited by 40
Lin, M., Ou, T., Chang, C.-H., Chan, K., & Wang, C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf505303s · Cited by 39
Chiu, T.-H., Lan, K.-Y., Yang, M., Lin, J., Hsia, T., Wu, C.-T., Yang, J., Chueh, F., & Chung, J. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2012.725503 · Cited by 39
Liu, W., Furuta, E., Shindo, K., Watabe, M., Xing, F., Pandey, P. R., Okuda, H., Pai, S. K., Murphy, L. L., Cao, D., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1076-8 · Cited by 38
Chen, X., Wong, Y., Lim, T. K., Lim, W., Lin, Q., Wang, J., & Hua, Z. (2017) · Molecules · doi:10.3390/molecules22081272 · Cited by 38
Menéndez, J., Vellon, L., & Lupu, R. (2005) · Experimental biology and medicine · doi:10.1177/153537020523000301 · Cited by 28
Zhao, C., Mitchell, T. A., Vallakati, R., Pérez, L. M., & Romo, D. (2011) · Journal of the American Chemical Society · doi:10.1021/ja209163w · Cited by 33
Mechanism of Orlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase
Fako, V. E., Zhang, J., & Liu, J. (2014) · ACS Catalysis · doi:10.1021/cs500956m · Cited by 32
Cioccoloni, G., Aquino, A., Notarnicola, M., Caruso, M. G., Bonmassar, E., Zonfrillo, M., Caporali, S., Faraoni, I., Villivà, C., Fuggetta, M. P., et al. (2019) · Journal of Chemotherapy · doi:10.1080/1120009x.2019.1694761 · Cited by 32
Novel antagonists of the thioesterase domain of human fatty acid synthase
Richardson, R. D., & Smith, J. W. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0187 · Cited by 27
Self-citationThe peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy
Carvalho, T. M. A., Cardoso, H. J., Figueira, M. I., Vaz, C. V., & Socorro, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.053 · Cited by 27
Strickland, K. C., Hoeferlin, L. A., Oleinik, N. V., Krupenko, N. I., & Krupenko, S. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.080556 · Cited by 26
Sippel, K. H., Vyas, N. K., Zhang, W., Sankaran, B., & Quiocho, F. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.608547 · Cited by 25
Huang, H., Tang, J. P., Zhou, S., Yi, T., Peng, H., Shen, G., Xie, N., Huang, K., Yang, T., Wu, J., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1465 · Cited by 25
Sowa, Y. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1353 · Cited by 25
Kumaraswamy, G., & Markondaiah, B. (2007) · Tetrahedron Letters · doi:10.1016/j.tetlet.2007.11.051 · Cited by 25
Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives
Irshad, R., Tabassum, S., & Husain, M. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230522103321 · Cited by 25
Aubry, S., Aubert, G., Cresteil, T., & Crich, D. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob06976h · Cited by 24
Targeting Cancer Metabolism and Current Anti-Cancer Drugs
Sukjoi, W., Ngamkham, J., Attwood, P. V., & Jitrapakdee, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_2 · Cited by 23
β-Lactam congeners of orlistat as inhibitors of fatty acid synthase
Zhang, W., Richardson, R. D., Chamni, S., Smith, J. W., & Romo, D. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.043 · Cited by 23
Self-citationAlmeida, L. Y., MOREIRA, F. D. S., dos Santos, G. A., Zelaya, F. J. M. C., Rojas, C. A. O., Agostini, M., Mariano, F. S., Bastos, D. C., Nicolau, U. R., Kowalski, L. P., et al. (2021) · Oral Diseases · doi:10.1111/odi.14017 · Cited by 21
Dai, W., Wang, Z., Wang, G., Wang, Q. A., DeBerardinis, R. J., & Jiang, L. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112971 · Cited by 20
Ueda, S. M., Mao, T., Kuhajda, F. P., Vasoontara, C., Giuntoli, R. L., Bristow, R. E., Kurman, R. J., & Shih, I. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081162 · Cited by 20
Deepa, P. R., Vandhana, S., & Krishnakumar, S. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.748923 · Cited by 20
Little, J. L., Wheeler, F. B., Koumenis, C., & Kridel, S. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0558 · Cited by 20
Cut the fat: targeting cholesterol and lipid metabolism in glioblastoma
Zekanovic, S., Sing, P. A., Leenstra, S., & Lamfers, M. L. M. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07993-3 · Cited by 16
Almeida, L. Y., Mariano, F. S., Bastos, D. C., Cavassani, K. A., Raphelson, J. R., Mariano, V. S., Agostini, M., Moreira, F. S., Coletta, R. D., Mattos‐Graner, R. O., et al. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-04010-1 · Cited by 16
Sangeetha, M., Deepa, P. R., Rishi, P., Khetan, V., & Krishnakumar, S. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25217 · Cited by 17
A fast-acting lipid checkpoint in G1 prevents mitotic defects
Köberlin, M. S., Fan, Y., Liu, C., Chung, M., Pinto, A. F. M., Jackson, P. K., Saghatelian, A., & Meyer, T. (2024) · Nature Communications · doi:10.1038/s41467-024-46696-9 · Cited by 15
Orlistat treatment induces apoptosis and arrests cell cycle in HSC-3 oral cancer cells
Xiao, X., Liu, H., & Li, X. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.09.001 · Cited by 15
Obesity, fatty acid synthase, and cancer: serendipity or forgotten causal linkage?
Menéndez, J. A., Colomer, R., & Lupu, R. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.10.007 · Cited by 15
Fatty acid synthase as a potential new therapeutic target for cervical cancer
Nascimento, J., Mariot, C. D. S., Vianna, D. R. B., Kliemann, L. M., Chaves, P., Loda, M. F., Buffon, A., Beck, R. C. R., & Pilger, D. A. (2022) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202220210670 · Cited by 14
Revealing protein networks and gene-drug connectivity in cancer from direct information
Jiang, X., Martínez-Ledesma, E., & Morcos, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-04001-3 · Cited by 14
Metadata
- Authors
- Knowles, L. M., Axelrod, F., Browne, C. D., & Smith, J. W.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Smith, Jeffrey W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 279
- Issue
- 29
- Pages
- 30540-30545
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2115307821
- Cited by
- 146
- References
- 38
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 5 · 2022: 2 · 2021: 4 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 4 · 2015: 5 · 2014: 12 · 2013: 6 · 2012: 13
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA30199, CA-69306, R01CA069306, CA6982713, P30CA030199)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- fatty acid synthase, Skp2, orlistat, cell cycle arrest, G1/S checkpoint, p27, ubiquitin-mediated proteolysis, E3 ubiquitin ligase, tumor cell proliferation, siRNA knockdown, cancer drug targets
- MeSH terms
- Orlistat, Avidin, Biotin, Cell Cycle, Cell Division, Cell Line, Dose-Response Relationship, Drug, Epithelial Cells, Fatty Acids, Humans, Lactones, Lipase, Obesity, Serine Endopeptidases, Time Factors, Blotting, Western, Down-Regulation, Retinoblastoma Protein, G1 Phase, S Phase, Cell Cycle Proteins, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Palmitic Acid, Tumor Suppressor Proteins, Ubiquitin, RNA, Small Interfering, Ubiquitin-Protein Ligases, S-Phase Kinase-Associated Proteins, Cell Line, Tumor, Cyclin-Dependent Kinase Inhibitor p27, Fatty Acid Synthases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review